- Home
- KYMR vs OR Comparison
KYMR vs OR Comparison
Compare KYMR & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | OR |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.5B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KYMR | OR |
|---|---|---|
| Price | $83.62 | $39.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 26 | 4 |
| Target Price | ★ $107.72 | $38.75 |
| AVG Volume (30 Days) | 575.0K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $11.85 | $100.08 |
| Revenue Next Year | $7.79 | $13.87 |
| P/E Ratio | ★ N/A | $55.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.45 | $19.32 |
| 52 Week High | $103.00 | $48.06 |
Technical Indicators
Market Signals| Indicator | KYMR | OR |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 52.27 |
| Support Level | $77.78 | $38.38 |
| Resistance Level | $95.90 | $42.25 |
| Average True Range (ATR) | 3.76 | 1.74 |
| MACD | 0.70 | 0.63 |
| Stochastic Oscillator | 76.54 | 86.25 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About OR Osisko Gold Royalties Ltd
OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.